United States: FDA Flexes Its New FDORA Muscles In Withdrawing An Accelerated Approval - Hyman, Phelps, & McNamara
On Friday, February 23, 2024, FDA announced its final decision to withdraw the approval of Pepaxto (melphalan flufenamide), which was approved...
Full Article